In the most recent in a series of efforts intended to push it further into molecular diagnostics, Invitrogen said this week that it would collaborate with German firm Signalomics to develop nanocrystal reagents for tumor identification.

The company also said it "welcomes" existing and impending competition from small, private shops because they will eventually become "collaboration" opportunities for Invitrogen.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.